Published • loading... • Updated
CU Anschutz Clinical Trial Finds GLP-1s Help Curb Alcohol Use Disorder
Summary by 9NEWS Denver
2 Articles
2 Articles
GLP-1s could be linked to more than 150 deaths
GLP-1 drugs including semaglutide, liraglutide and tirzepatide may be linked to more than 150 deaths and thousands of adverse reactions, according to the UK's Medicines and Healthcare Products Regulatory Agency (MHRA), specifically data collected by its Yellow Card biobank. Alongside deaths, the drugs are suspected of having been linked to gastrointestinal symptoms, psychiatric disorders and nervous system disorders.
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
